Lucid Diagnostics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Lucid Diagnostics Inc. (LUCD) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents22.3618.9022.4753.660.11
Short-Term Investments0.001.981.331.120.12
Cash & Short-Term Investments22.3618.9022.4753.660.23
Accounts Receivable0.050.050.020.200.00
Inventory0.340.280.110.490.83
Other Current Assets2.040.610.051.580.00
Total Current Assets25.1522.0724.3657.301.44
Non-Current Assets
Property, Plant & Equipment (Net)3.702.643.600.970.00
Intangible Assets0.741.423.450.000.00
Other Non-Current Assets1.131.131.110.730.76
Total Non-Current Assets5.575.208.151.700.00
Total Assets30.7227.2732.5159.002.20
Current Liabilities
Accounts Payable1.241.152.501.492.06
Short-Term Debt18.6013.950.000.000.00
Accrued Liabilities0.932.116.120.563.07
Other Current Liabilities0.420.554.960.6210.58
Total Current Liabilities23.5229.388.434.2615.71
Non-Current Liabilities
Long-Term Debt1.800.201.040.000.00
Other Non-Current Liabilities0.009.340.001.660.00
Total Non-Current Liabilities1.800.201.041.660.00
Total Liabilities25.3229.589.464.2615.71
Stockholders' Equity
Common Stock0.060.040.040.040.01
Retained Earnings-203.77-150.74-98.08-41.90-13.83
Additional Paid-in Capital154.68129.76121.0896.610.00
Shares Outstanding63.0742.3340.5234.920.00
Total Stockholders' Equity5.39-2.3123.0554.74-13.52
Total Liabilities & Equity30.7227.2732.5159.000.00